Your browser is no longer supported. Please, upgrade your browser.
Settings
SGYP Synergy Pharmaceuticals Inc. daily Stock Chart
SGYP [NASD]
Synergy Pharmaceuticals Inc.
Index- P/E- EPS (ttm)-1.00 Insider Own1.56% Shs Outstand252.10M Perf Week-3.24%
Market Cap451.26M Forward P/E- EPS next Y-0.24 Insider Trans-69.06% Shs Float242.83M Perf Month-7.25%
Income-224.30M PEG- EPS next Q-0.16 Inst Own53.70% Short Float24.87% Perf Quarter-20.80%
Sales16.80M P/S26.86 EPS this Y17.60% Inst Trans-0.09% Short Ratio11.73 Perf Half Y-41.12%
Book/sh-0.02 P/B- EPS next Y57.90% ROA-154.30% Target Price7.08 Perf Year-57.07%
Cash/sh0.54 P/C3.29 EPS next 5Y- ROE-640.90% 52W Range1.68 - 4.84 Perf YTD-19.73%
Dividend- P/FCF- EPS past 5Y-9.30% ROI-201.10% 52W High-63.02% Beta1.21
Dividend %- Quick Ratio3.90 Sales past 5Y- Gross Margin47.60% 52W Low6.55% ATR0.08
Employees313 Current Ratio4.30 Sales Q/Q- Oper. Margin- RSI (14)40.78 Volatility4.07% 5.00%
OptionableYes Debt/Eq- EPS Q/Q49.90% Profit Margin- Rel Volume0.34 Prev Close1.79
ShortableYes LT Debt/Eq- EarningsMar 01 AMC Payout- Avg Volume5.15M Price1.79
Recom2.30 SMA20-3.24% SMA50-8.19% SMA200-32.05% Volume1,767,166 Change0.00%
Jan-05-18Downgrade Oppenheimer Outperform → Perform
Sep-25-17Reiterated H.C. Wainwright Buy $15 → $8
Sep-13-17Reiterated Citigroup Sell $3.20 → $2.50
Sep-08-17Reiterated Oppenheimer Outperform $9 → $6
Aug-10-17Reiterated Rodman & Renshaw Buy $18 → $15
Apr-06-17Downgrade Citigroup Neutral → Sell
Jan-20-17Reiterated Rodman & Renshaw Buy $17 → $18
Jan-05-17Initiated Oppenheimer Outperform
Dec-23-16Reiterated Rodman & Renshaw Buy $16 → $17
Dec-18-15Downgrade Citigroup Buy → Neutral
Oct-29-15Resumed ROTH Capital Buy $9.50
Jun-18-15Reiterated Canaccord Genuity Buy $11 → $19
May-22-15Initiated Canaccord Genuity Buy $11
Nov-18-14Reiterated ROTH Capital Buy $8.50 → $6
Aug-12-13Reiterated Cantor Fitzgerald Buy $15 → $11
Apr-09-13Reiterated Cantor Fitzgerald Buy $12 → $15
Jan-02-13Reiterated Cantor Fitzgerald Buy $7 → $13
Sep-25-12Initiated Cantor Fitzgerald Buy $7
Apr-18-18 08:51AM  Options Traders Expect Huge Moves in Synergy Pharmaceuticals (SGYP) Stock Zacks
Apr-11-18 08:00AM  Biotech Guru Samuel Isaly Bets on scPharmaceuticals (SCPH), Throws in the Towel on Synergy Pharmaceuticals (SGYP) Investopedia
Apr-10-18 10:45AM  DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Synergy Pharmaceuticals Inc. and Reminds Investors With Losses In Excess of $50,000 to Contact The Firm ACCESSWIRE
10:30AM  Glancy Prongay & Murray LLP Reminds Investors of the April 10, 2018 Deadline in the Class Action Lawsuit Against Synergy Pharmaceuticals Inc. (SGYP) Business Wire
10:05AM  SGYP DEADLINE TODAY: The Law Offices of Vincent Wong Reminds Investors of Class Actions Involving Synergy Pharmaceuticals Inc. and a Lead Plaintiff Deadline of April 10, 2018 ACCESSWIRE
10:00AM  FINAL DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Synergy Pharmaceuticals Inc. (SGYP) & Lead Plaintiff Deadline: April 10, 2018 GlobeNewswire
Apr-09-18 06:56PM  Glancy Prongay & Murray LLP Announces the Filing of a Securities Class Action on Behalf of Synergy Pharmaceuticals Inc. Investors (SGYP) Business Wire
05:19PM  EQUITY NOTICE: Rosen Law Firm Reminds Synergy Pharmaceuticals Inc. Investors of Important April 10, 2018 Deadline in Class Action SGYP Business Wire
03:38PM  FINAL DEADLINE TOMORROW: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Synergy Pharmaceuticals Inc. And Reminds Investors With Losses In Excess of $50,000 To Contact The Firm ACCESSWIRE
03:30PM  DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Synergy Pharmaceuticals, Inc. (SGYP) and Encourages Investors to Contact the Firm Before April 10th ACCESSWIRE
03:03PM  DEADLINE TOMORROW: Levi & Korsinsky, LLP Reminds Shareholders of Synergy Pharmaceuticals Inc. of Class Actions and a Lead Plaintiff Deadline of April 10, 2018 SGYP ACCESSWIRE
Apr-07-18 01:30PM  DEADLINE TUESDAY: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Synergy Pharmaceuticals Inc. And Reminds Investors With Losses In Excess of $100,000 To Contact The Firm ACCESSWIRE
Apr-06-18 06:00PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Synergy Pharmaceuticals Inc. of Class Action Lawsuit and Upcoming Deadline - SGYP ACCESSWIRE
11:41AM  APRIL 10 DEADLINE: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Synergy Pharmaceuticals Inc. And Reminds Investors With Losses In Excess of $100,000 To Contact The Firm ACCESSWIRE
Apr-05-18 05:30PM  Synergy Pharmaceuticals Inc. Reminder: Important April 10, 2018 Lead Plaintiff Deadline in Class Action SGYP ACCESSWIRE
04:28PM  SGYP UPCOMING DEADLINE: The Law Offices of Vincent Wong Reminds Investors of Class Actions Involving Synergy Pharmaceuticals Inc. and a Lead Plaintiff Deadline of April 10, 2018 ACCESSWIRE
11:25AM  5-Day Deadline Alert: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Synergy Pharmaceuticals Inc. And Reminds Investors With Losses In Excess of $100,000 To Contact The Firm ACCESSWIRE
11:00AM  Kessler Topaz Meltzer & Check, LLP: Final Deadline Reminder For Synergy Pharmaceuticals Inc. Shareholders - SGYP ACCESSWIRE
Apr-04-18 04:15PM  DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Synergy Pharmaceuticals, Inc. (SGYP) and Encourages Investors to Contact the Firm Before April 10th ACCESSWIRE
03:14PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Synergy Pharmaceuticals Inc. of Class Action Lawsuit and Upcoming Deadline SGYP Business Wire
02:18PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Synergy Pharmaceuticals Inc. of Class Actions and a Lead Plaintiff Deadline of April 10, 2018 - SGYP ACCESSWIRE
12:42PM  TUESDAY DEADLINE: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Synergy Pharmaceuticals Inc. And Reminds Investors With Losses In Excess of $100,000 To Contact The Firm ACCESSWIRE
Apr-03-18 03:40PM  The Klein Law Firm Reminds Investors of Commencement of Class Actions on Behalf of Synergy Pharmaceuticals Inc. Shareholders and a Lead Plaintiff Deadline of April 10, 2018 ACCESSWIRE
11:35AM  7-Day Deadline Alert: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Synergy Pharmaceuticals Inc. And Reminds Investors With Losses In Excess of $100,000 To Contact The Firm ACCESSWIRE
Apr-02-18 09:22PM  Glancy Prongay & Murray LLP Continues Investigation on Behalf of Synergy Pharmaceuticals Inc. Investors (SGYP) Business Wire
03:08PM  SGYP INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of Class Actions Involving Synergy Pharmaceuticals Inc. and a Lead Plaintiff Deadline of April 10, 2018 ACCESSWIRE
11:30AM  DEADLINE APPROACHING: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Synergy Pharmaceuticals Inc. And Reminds Investors With Losses In Excess of $100,000 To Contact The Firm ACCESSWIRE
11:00AM  Kessler Topaz Meltzer & Check, LLP: Important Deadline Reminder for Synergy Pharmaceuticals Inc. Shareholders ACCESSWIRE
10:44AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Synergy Pharmaceuticals Inc. (SGYP) & Lead Plaintiff Deadline: April 10, 2018 ACCESSWIRE
Apr-01-18 06:00AM  FINAL DEADLINE ALERT: Brower Piven Reminds Shareholders of Approaching Deadline in Class Action Lawsuit and Encourages Investors Who Have Losses in Excess of $100,000 from Investment in Synergy Pharmaceuticals Inc. to Contact the Firm Business Wire
Mar-31-18 12:00PM  3 Favorite Biotech Stocks for the Second Quarter TheStreet.com
11:05AM  APRIL 10 DEADLINE: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Synergy Pharmaceuticals Inc. And Reminds Investors With Losses In Excess of $100,000 To Contact The Firm ACCESSWIRE
06:27AM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on Their Investment in Synergy Pharmaceuticals Inc. of Class Action Lawsuit and Upcoming Deadline - SGYP ACCESSWIRE
Mar-30-18 01:50PM  IMPORTANT DEADLINE REMINDER: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Synergy Pharmaceuticals Inc. And Reminds Investors With Losses In Excess of $100,000 To Contact The Firm ACCESSWIRE
Mar-29-18 03:28PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Synergy Pharmaceuticals Inc. of Class Actions and a Lead Plaintiff Deadline of April 10, 2018 - SGYP ACCESSWIRE
Mar-28-18 05:25PM  APRIL 10 DEADLINE: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Synergy Pharmaceuticals Inc. And Reminds Investors With Losses In Excess of $100,000 To Contact The Firm ACCESSWIRE
02:45PM  The Klein Law Firm Reminds Investors of the Commencement of Class Actions on Behalf of Synergy Pharmaceuticals Inc. Shareholders and a Lead Plaintiff Deadline of April 10, 2018 ACCESSWIRE
01:05PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Synergy Pharmaceuticals Inc. of Class Action Lawsuit and Upcoming Deadline - SGYP ACCESSWIRE
11:00AM  Kessler Topaz Meltzer & Check, LLP Announces Class Action Lawsuit Filed Against Synergy Pharmaceuticals Inc. on Behalf of Shareholders ACCESSWIRE
Mar-27-18 06:19PM  Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Synergy Pharmaceuticals, Inc. (SGYP) and Encourages Investors to Contact the Firm Business Wire
Mar-26-18 03:00PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Synergy Pharmaceuticals Inc. of Commencement of Class Actions and a Lead Plaintiff Deadline of April 10, 2018 - SGYP ACCESSWIRE
10:50AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Synergy Pharmaceuticals Inc. (SGYP) & Lead Plaintiff Deadline: April 10, 2018 ACCESSWIRE
Mar-24-18 04:06PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Synergy Pharmaceuticals Inc. of Class Action Lawsuit and Upcoming Deadline - SGYP ACCESSWIRE
Mar-23-18 12:58PM  Synergy Pharmaceuticals Inc (NASDAQ:SGYP): Is Breakeven Near? Simply Wall St.
Mar-22-18 03:12PM  SGYP INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of Class Actions Involving Synergy Pharmaceuticals Inc. and a Lead Plaintiff Deadline of April 10, 2018 ACCESSWIRE
08:00AM  Kessler Topaz Meltzer & Check, LLP - Deadline Reminder for Synergy Pharmaceuticals Inc. Shareholders SGYP GlobeNewswire
Mar-21-18 08:22PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Synergy Pharmaceuticals Inc. of Class Action Lawsuit and Upcoming Deadline - SGYP ACCESSWIRE
11:36AM  EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Synergy Pharmaceuticals Inc. of Class Actions and a Lead Plaintiff Deadline of April 10, 2018 - SGYP ACCESSWIRE
10:21AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Synergy Pharmaceuticals Inc. (SGYP) and Lead Plaintiff Deadline: April 10, 2018 ACCESSWIRE
Mar-20-18 03:22PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Synergy Pharmaceuticals Inc. Shareholders and a Lead Plaintiff Deadline of April 10, 2018 GlobeNewswire
Mar-19-18 05:33PM  DEADLINE REMINDER: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Synergy Pharmaceuticals Inc. And Encourages Investors With Losses To Contact The Firm ACCESSWIRE
04:00PM  INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Synergy Pharmaceuticals Inc. of Class Actions and a Lead Plaintiff Deadline of April 10, 2018 - SGYP ACCESSWIRE
11:47AM  Synergy Pharmaceuticals Inc. Investors: Important April 10, 2018 Lead Plaintiff Deadline in Class Action- SGYP ACCESSWIRE
Mar-17-18 05:36PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Synergy Pharmaceuticals Inc. of Class Action Lawsuit and Upcoming Deadline - SGYP ACCESSWIRE
Mar-16-18 04:10PM  SYNERGY PHARMACEUTICALS, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for the Eastern District of New York against Synergy Pharmaceuticals, Inc. GlobeNewswire
Mar-15-18 01:27PM  SGYP EQUITY ALERT: The Law Offices of Vincent Wong Reminds Investors of Class Actions Involving Synergy Pharmaceuticals Inc. and a Lead Plaintiff Deadline of April 10, 2018 GlobeNewswire
10:20AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Synergy Pharmaceuticals Inc. (SGYP) and Lead Plaintiff Deadline: April 10, 2018 ACCESSWIRE
Mar-14-18 07:14PM  EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Synergy Pharmaceuticals Inc. of Class Actions and a Lead Plaintiff Deadline of April 10, 2018 SGYP GlobeNewswire
05:45PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Synergy Pharmaceuticals Inc. of Class Action Lawsuit and Upcoming Deadline - SGYP ACCESSWIRE
Mar-13-18 03:31PM  Lifshitz & Miller LLP Announces Investigation of A. Schulman, Inc., CSRA Inc., Infinity Property and Casualty Corporation, Layne Christensen Company, Microsemi Corporation, Quantum Corporation, and Synergy Pharmaceuticals Inc. PR Newswire
08:30AM  Synergy Pharmaceuticals to Present at Oppenheimer 28th Annual Healthcare Conference Business Wire
Mar-11-18 10:10AM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Synergy Pharmaceuticals Inc. of Class Action Lawsuit and Upcoming Deadline - SGYP ACCESSWIRE
Mar-09-18 11:36AM  IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Synergy Pharmaceuticals Inc. And Encourages Investors With Losses To Contact The Firm ACCESSWIRE
11:19AM  INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Synergy Pharmaceuticals Inc. of Class Actions and a Lead Plaintiff Deadline of April 10, 2018 - SGYP ACCESSWIRE
10:07AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Synergy Pharmaceuticals Inc. (SGYP) & Lead Plaintiff Deadline: April 10, 2018 GlobeNewswire
Mar-08-18 03:35PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Synergy Pharmaceuticals Inc. of Class Action Lawsuit and Upcoming Deadline - SGYP ACCESSWIRE
02:10PM  SGYP INVESTOR ALERT: The Law Offices of Vincent Wong Notifies Investors of Class Actions Involving Synergy Pharmaceuticals Inc. and a Lead Plaintiff Deadline of April 10, 2018 ACCESSWIRE
01:22PM  SHAREHOLDER ALERT: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Synergy Pharmaceuticals Inc. ACCESSWIRE
Mar-07-18 04:00PM  Hagens Berman Reminds Synergy Pharmaceuticals Investors of the April 10, 2018 Lead Plaintiff Deadline and Alerts them to the Expanded Class Period GlobeNewswire +5.69%
03:53PM  SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Synergy Pharmaceuticals Inc. (Nasdaq: SGYP) To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit GlobeNewswire
Mar-06-18 02:50PM  INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Synergy Pharmaceuticals Inc. of Class Actions and a Lead Plaintiff Deadline of April 10, 2018 - SGYP ACCESSWIRE -5.38%
11:00AM  SHAREHOLDER REMINDER: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Class Action Lawsuit Filed Against Synergy Pharmaceuticals Inc. Business Wire
Mar-05-18 12:13PM  The Klein Law Firm Reminds Investors of the Commencement of a Class Action on Behalf of Synergy Pharmaceuticals Inc. Shareholders and a Lead Plaintiff Deadline of April 10, 2018 Business Wire
Mar-03-18 12:00PM  SYNERGY ALERT: Faruqi & Faruqi, LLP Files Securities Fraud Class Action Complaint Against Synergy Pharmaceuticals, Inc. With Expanded Class Period GlobeNewswire
08:00AM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Synergy Pharmaceuticals Inc. of Class Action Lawsuit and Upcoming Deadline SGYP GlobeNewswire
Mar-02-18 04:55PM  Why Synergy Pharmaceuticals' Shares Soared 24% Today Motley Fool +24.00%
03:02PM  SGYP EQUITY ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Synergy Pharmaceuticals Inc. and a Lead Plaintiff Deadline of April 10, 2018 Business Wire
08:30AM  Todays Research Reports on Trending Tickers: Catabasis Pharmaceuticals and Synergy Pharmaceuticals ACCESSWIRE
07:40AM  Blog Exposure - Cipher Pharma Acquired Canadian Rights to Synergy Pharmas FDA-Approved TRULANCE(R) ACCESSWIRE
Mar-01-18 06:54PM  Synergy Pharma reports 4Q loss Associated Press
04:30PM  EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Synergy Pharmaceuticals Inc. of a Class Action and a Lead Plaintiff Deadline of April 10, 2018 Business Wire
04:20PM  Synergy Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results and Business Update Business Wire
12:00PM  Synergy Pharmaceuticals, Inc. to Host Earnings Call ACCESSWIRE
Feb-28-18 04:20PM  IMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Synergy Pharmaceuticals Inc. ACCESSWIRE
03:25PM  The Klein Law Firm Announces the Commencement of a Class Action on Behalf of Synergy Pharmaceuticals Inc. Shareholders and a Lead Plaintiff Deadline of April 10, 2018 Business Wire
11:00AM  Kessler Topaz Meltzer & Check, LLP Reminds Synergy Pharmaceuticals Inc. Shareholders of Important Deadline in Class Action Lawsuit ACCESSWIRE
10:27AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Synergy Pharmaceuticals Inc. (SGYP) & Lead Plaintiff Deadline: April 10, 2018 ACCESSWIRE
09:30AM  Hagens Berman Reminds Synergy Pharmaceuticals Investors of the April 10, 2018 Lead Plaintiff Deadline in the Securities Class Action Linked to Loan Disclosures GlobeNewswire
07:01AM  Cipher Pharmaceuticals Reports Q4 & FY2017 Results CNW Group
07:00AM  Cipher Pharmaceuticals Acquires Exclusive Canadian Rights to FDA-Approved TRULANCE® from Synergy Pharmaceuticals CNW Group
Feb-27-18 07:20PM  DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Synergy Pharmaceuticals Inc. ACCESSWIRE
03:31PM  The Klein Law Firm Announces a Class Action Filed on Behalf of Synergy Pharmaceuticals Inc. Shareholders and a Lead Plaintiff Deadline of April 10, 2018 GlobeNewswire
12:55PM  Pawar Law Group Reminds Synergy Pharmaceuticals Inc. Investors of Important April 10, 2018 Lead Plaintiff Deadline in Class Action - SGYP ACCESSWIRE
Feb-26-18 02:09PM  SGYP INVESTOR ALERT: The Law Offices of Vincent Wong Notifies Investors of a Class Action Involving Synergy Pharmaceuticals Inc. and a Lead Plaintiff Deadline of April 10, 2018 Business Wire
12:09PM  INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Synergy Pharmaceuticals Inc. ACCESSWIRE
Feb-24-18 03:22PM  Investor Alert: Kaplan Fox Announces Investigation Of Synergy Pharmaceuticals Inc. PR Newswire
Feb-23-18 05:30PM  Safirstein Metcalf LLP Announces that a Class Action has been Filed Against Synergy Pharmaceuticals Inc - SGYP GlobeNewswire
04:26PM  SGYP SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of Commencement of a Class Action Involving Synergy Pharmaceuticals Inc. and a Lead Plaintiff Deadline of April 10, 2018 GlobeNewswire
03:01PM  IMPORTANT INVESTOR ALERT FOR ALL OWNERS OF SYNERGY PHARMACEUTICALS, INC.: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for the Eastern District of New York against Synergy Pharmaceuticals, Inc. GlobeNewswire
11:00AM  Kessler Topaz Meltzer & Check, LLP - Important Deadline Reminder for Synergy Pharmaceuticals Inc. Shareholders GlobeNewswire
Synergy Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies to treat gastrointestinal diseases and disorders. Its lead product is plecanatide, a novel uroguanylin based gastrointestinal platform that is traded under the TRULANCE name for the treatment of chronic idiopathic constipation and irritable bowel syndrome. The company also develops dolcanatide to treat mild-to-moderate ulcerative colitis. It has a licensing agreement with Cipher Pharmaceuticals Inc. to develop, market, distribute, and sell TRULANCE in Canada. Synergy Pharmaceuticals Inc. is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BRANCACCIO JOHN PDirectorApr 02Option Exercise0.5050,00025,00076,944Apr 02 05:00 PM
PAULSON & CO. INC.10% OwnerNov 10Sale2.828,750,00024,678,50015,312,368Nov 14 04:36 PM
PAULSON & CO. INC.10% OwnerAug 07Sale3.7726,28798,97224,062,368Aug 09 06:17 PM
BRANCACCIO JOHN PDirectorMay 26Buy3.596,50023,33530,444May 30 07:56 AM
JACOB GARY SChief Executive OfficerMay 26Buy3.525,68019,967402,679May 30 07:55 AM